Avantor Inc. was named Best Bioprocessing Supplier in Single-Use Manufacturing at the Asia-Pacific Bioprocessing Excellence Awards 2021 held recently.
The award recognizes Avantor’s contributions in facilitating biomanufacturing excellence with enhanced speed, reduced cost and superior quality, and reaffirms its critical role in biomanufacturing of biologics. Avantor was also awarded Best Company in Bioprocessing Excellence for Single-use Solutions at Biologics Manufacturing Korea 2020.
Narayana Rao Rapolu, Vice President, Biopharma Asia Middle East & Africa for the Company said, “Avantor has long been an open-architecture, single-use provider, offering complete design, manufacturing and logistics to support every stage of the biomanufacturing process. Our work in biopharma has never been more important. From the small-scale bench, to pilot plant and full commercial manufacturing, we enable our customers to reach the market with new treatments for patients – faster, safer and smarter.”
Significance of single-use technologies:
- Robust and scalable, enabling transformative treatments to reach more patients globally.
- According to BioPharm International, a publication that integrates the science and business of biopharmaceuticals, single-use technologies are used in nearly 85% of pre-commercial manufacturing of biologics.
- Applications of biologics include monoclonal antibodies (mAbs) used in therapeutic solutions for immune-oncology and immunotherapy and cell and gene therapies which help to treat challenging illnesses, such as some cancers and genetic diseases.
